SYNIMMUNE SYNIMMUNE is a biotechnology company dedicated to the development of mono- and bispecific anti-tumor antibodies. | ![]() Ascendis Pharma Ascendis Pharma is a biopharmaceutical company that specializes in endocrinology and oncology. | TRON TRON Mainz is a biopharmaceutical research organization that offers diagnostics and drugs for the treatment of cancer and other severe diseases. | AnaptysBio AnaptysBio is a biotechnology company developing immunology therapeutic product candidates. | ![]() Allogene Therapeutics Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer. | |
Founding Date | Founding Date 2010 | Founding Date 2007 | Founding Date 2010 | Founding Date 2005 | Founding Date 2018 |
Type | Type Private | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Tübingen, DE HQ | Locations Hellerup, DK HQ Heidelberg, DE Palo Alto, US | Locations Mainz, DE HQ | Locations San Diego, US HQ San Diego, US | Locations South San Francisco, US HQ |
Employees | Employees 5 | Employees 1,017 | Employees 1903% increase | Employees 898% decrease | Employees 2263% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 7.7 b | Valuation ($) N/A | Valuation ($) 930.2 m | Valuation ($) 585.5 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €720.1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $234.6m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income N/A | Net income (€228m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($190.9m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 85.8m | Total funding raised N/A | Total funding raised $ 83.9m | Total funding raised $ 532m |

Ascendis Pharma is a biopharmaceutical company that specializes in endocrinology and oncology.
View companyTRON Mainz is a biopharmaceutical research organization that offers diagnostics and drugs for the treatment of cancer and other severe diseases.
View companyAnaptysBio is a biotechnology company developing immunology therapeutic product candidates.
View company
Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer.
View company